I still don't understand why people love to crunch numbers, all...

First 2 Last

Share
Profile

Follow
airman08

1,015 Posts.

50

15/01/17

10:37

Post #: 21902621
Share

Originally posted by slc4me ↑

OK - there has been some outlandish numbers thrown around as to what could be the half year sales number - not to mention some stupid bet made by some intellectual challenged poster.

It is time to put up or shut up. The nearest to the pin competition is now on. The winner gets 6 months of bragging rights and shall be lauded throughout the land (including NZ & China) as the smartest and most insightful poster of A2M. Their posts shall command respect and always receive a thumbs up - they will be always known in future posts as "the insightful one".

So the rules are:

1) Numbers in $NZ.
2) In millions to one decimal point (ie $235,100,000 shall be posted as $235.1m)
3) If two numbers the same then whoever posted 1st wins on countback
4) No range - this means you Marko! One number and one number only.
5) No rational reason is required but it would be nice to justify your number so as to make this thread worthwhile rather than just a pure guessing game.
6) I determine who wins - but I promise to be as transparent as a politician claiming a travel allowance.
7) The game is to be played in a positive spirit, ie justify your own numbers - It is not to critique and rubbish other posters.

So I go first:

My half year number is $241.3m. It is based on the October ytd number of $155.2m plus an additional $86.1m for Nov & Dec. Infant Formula for China will be the key driver of growth. While many other posters will say I am being very pessimistic in regards to the growth I am of the view the exceptional October number (ex factory sales) is reflected in the market share coming through in Nov.

I look forward to your numbers (and hold up on buying the cherries - they are very expensive at the moment).

Cheers

slc4me

Expand

I still don't understand why people love to crunch numbers, all these numbers are legally & financially adjustable. BAL has always put on some beautiful numbers but still collapsed over night.

If you are really free, pay some visits to your local supermarkets/pharmacies/popup stores to observe and collect some useful information.

Thank you

A2M Price at posting: $2.12 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 113 more messages in this thread...

First 2 Last

Add A2M (ASX) to my watchlist

(20min delay)
Last $6.78		Change 0.070(1.04%)		Mkt cap ! $4.887B

Open	High	Low	Value	Volume
$6.72	$6.80	$6.70	$4.795M	709.6K

Buyers (Bids)

No.	Vol.	Price($)
14	8394	$6.77

Sellers (Offers)

Price($)	Vol.	No.
$6.78	6869	15

View Market Depth

No.	Vol.	Price($)
15	9088	6.770
15	10428	6.760
26	47507	6.750
9	9200	6.740
11	11101	6.730

Price($)	Vol.	No.
6.780	5516	14
6.790	36743	20
6.800	36396	22
6.810	20047	10
6.820	11487	14

Last trade - 14.41pm 09/07/2024 (20 minute delay)

A2M (ASX) Chart

I still don't understand why people love to crunch numbers, all...

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I still don't understand why people love to crunch numbers, all...

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News